Items where authors include "Spoletini, G"

Article

Peckham, D orcid.org/0000-0001-7723-1868 and Spoletini, G (2023) Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis. Seminars in Respiratory and Critical Care Medicine, 44 (02). pp. 217-224. ISSN 1069-3424

Spoletini, G orcid.org/0000-0002-5462-0083, Fitch, G, Gillgrass, L et al. (3 more authors) (2022) Urinary bicarbonate and metabolic alkalosis during exacerbations in cystic fibrosis. ERJ Open Research, 8 (2). 00669-2021. ISSN 2312-0541

Spoletini, G, Gillgrass, L, Pollard, K et al. (5 more authors) (2022) Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis. Journal of Cystic Fibrosis, 21 (6). pp. 1061-1065. ISSN 1569-1993

Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Scambler, T, Wong, CH orcid.org/0000-0003-2108-1615 et al. (11 more authors) (2020) Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. eLife, 9. e54556. ISSN 2050-084X

Spoletini, G orcid.org/0000-0002-5462-0083, Kennedy, M, Flint, L et al. (7 more authors) (2018) Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre. Pulmonary Pharmacology & Therapeutics, 50. pp. 82-87. ISSN 1094-5539

Sawant, A, Spoletini, G, Whitaker, P et al. (3 more authors) (2018) Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis. ERJ Open Research, 4 (1). 00111-2017. ISSN 2312-0541

Conference or Workshop Item

Haigh, L, Chadwick, HK, Gillgrass, L et al. (10 more authors) (2021) P206 Patient feedback following the introduction of a dedicated ‘Symkevi® Initiation Clinic’ prior to starting modulator therapy. In: 44th European Cystic Fibrosis Conference.

Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2020) Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial. In: 2020 ERS International Congress, 06-09 Sep 2020, Online.

Lim, Y, Etherington, C, Spoletini, G et al. (2 more authors) (2020) Cancer risk in cystic fibrosis patients: a 13-year experience in a UK regional centre. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.

Jarosz-Griffiths, H, Scambler, T, Wong, C et al. (11 more authors) (2020) WS12.6 Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. In: 43rd European Cystic Fibrosis Conference, 24-25 Sep 2020, Online.

Spoletini, G, Pollard, K, Watson, R et al. (4 more authors) (2019) Outcomes at 6 months following NIV in adults with cystic fibrosis (CF): experience of a large UK centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.

Spoletini, G, Watson, R, Pollard, K et al. (4 more authors) (2019) Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre. In: ERS International Congress 2019, 28 Sep - 02 Oct 2019, Madrid, Spain.

Proceedings Paper

Gillgrass, L, Haigh, L, Pollard, K et al. (6 more authors) (2023) P366 Developing an in-house and integrated sweat testing service for the routine management of adults with cystic fibrosis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier , S176-S176.

Sawant, AP, Chadwick, HK orcid.org/0000-0002-8022-5490, White, H et al. (7 more authors) (2018) Views of healthcare professionals on patients having access to their secondary care electronic healthcare record: results of a cross-sectional questionnaire. In: Journal of Cystic Fibrosis. 41st European Cystic Fibrosis Conference, 06-09 Jun 2018, Belgrade, Serbia. Elsevier , S126-S126.

Spoletini, G orcid.org/0000-0002-5462-0083, Sawant, A, Etherington, C et al. (4 more authors) (2018) Bicarbonate and oxygen saturation predict the need for fitness to fly test in patients with cystic fibrosis. In: Journal of Cystic Fibrosis. 41st European Cystic Fibrosis Conference, 06-09 Jun 2018, Belgrade, Serbia. Elsevier , S94-S94.